Direxion Daily Phrmctcl&MdclBl3XShrsETF (PILL)

18.33 +0.62  +3.51% NYSE Arca Dec 6, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 18.39
Discount or Premium to NAV -0.31%
Turnover Ratio 152.0%
1 Year Fund Level Flows 6.654M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 22.75% 22.99% -- --
3M 44.08% 44.31% -- --
6M 11.95% 12.33% -- --
YTD -13.48% -14.23% -- --
1Y -34.46% -34.66% -- --
3Y -- -- -- --
5Y -- -- -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of Dec. 6, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 1.31% 19.44% 18.12%
Stock 98.69% 98.69% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Nov. 30, 2019

Region Exposure

Americas 95.46%
North America 95.46%
Latin America 0.00%
Greater Europe 3.56%
United Kingdom 3.56%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.98%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.98%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Nov. 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Nov. 30, 2019

Stock Market Capitalization

Giant 22.03%
Large 8.67%
Medium 31.43%
Small 33.66%
Micro 4.22%
As of Nov. 30, 2019

Stock Style Exposure

Large Cap Value 13.33%
Large Cap Blend 13.57%
Large Cap Growth 4.14%
Mid Cap Value 7.40%
Mid Cap Blend 15.16%
Mid Cap Growth 9.22%
Small Cap Value 6.23%
Small Cap Blend 9.62%
Small Cap Growth 21.33%
As of Nov. 30, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Future on SPDR® S&P Pharmaceuticals ETF Dec49 19.65% -- --
RETA Reata Pharmaceuticals Inc A 3.97% 199.32 -0.12%
HZNP Horizon Therapeutics PLC 3.94% 32.23 +1.16%
BMY Bristol-Myers Squibb Company 3.65% 59.95 +0.79%
JAZZ Jazz Pharmaceuticals PLC 3.64% 149.46 +0.92%
AGN Allergan PLC 3.53% 186.37 +0.16%
LLY Eli Lilly and Co 3.35% 119.64 -0.11%
MRK Merck & Co Inc 3.34% 88.85 +0.11%
JNJ Johnson & Johnson 3.33% 140.38 +0.59%
PFE Pfizer Inc 3.31% 38.29 +0.68%
As of Nov. 30, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Mid Cap/Blend
Fixed Income Style --
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Growth and Income
Fund Owner Firm Name Direxion Funds
Benchmark Index
S&P Pharms Select Industry TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Paul Brigandi 2.04 yrs
Tony Ng 2.04 yrs

Net Fund Flows

1M 0.00
3M -8.148M
6M -2.427M
YTD 6.654M
1Y 6.654M
3Y --
5Y --
10Y --
As of Nov. 30, 2019

Risk Info

Beta (5Y) --
Max Drawdown (All) 69.65%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) -0.0993
30-Day Rolling Volatility 51.41%
Daily Value at Risk (VaR) 1% (All) 9.25%
Monthly Value at Risk (VaR) 1% (All) 30.49%

Fundamentals

Dividend Yield TTM (12-6-19) 1.06%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 23.83
Weighted Average Price to Sales Ratio 2.888
Weighted Average Price to Book Ratio 3.060
Weighted Median ROE 8.50%
Weighted Median ROA -6.53%
Forecasted Dividend Yield 0.79%
Forecasted PE Ratio 11.15
Forecasted Price to Sales Ratio 2.465
Forecasted Price to Book Ratio 1.740
Number of Holdings 46
As of Nov. 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 7.78%
Forecasted Book Value Growth 7.94%
Forecasted Cash Flow Growth 0.61%
Forecasted Earnings Growth 27.08%
Forecasted Revenue Growth 0.35%
As of Nov. 30, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 11/15/2017
Termination Date
Last Annual Report Date 10/31/2018
Last Prospectus Date 2/28/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.